Loading
Latest filing published 15 Aug 2026 for Prostatype Genomics AB, €47k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Anders Lundberg on record concern Prostatype Genomics AB, in the capacity of board member. The record holds 2 filings, for trades running from 3 October 2025 to 12 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 15 August 2026, reports a transaction of €47k in Prostatype Genomics AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations